Role of fibronectin in intravesical BCG therapy for superficial bladder cancer

Journal of Urology

Volumn 139, Issue 2, 1988, Pages

  Ratliffe, T L ^a   Kavoussi, L R ^a   Catalona, W J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BCG VACCINE; FIBRONECTIN;

ANIMAL; ANIMAL EXPERIMENT; BLADDER CANCER; HISTOLOGY; MOUSE; PRIORITY JOURNAL; SUPERFICIAL CANCER; TOPICAL DRUG ADMINISTRATION;

EID: 0023840266     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(17)42445-1     Document Type: Article

References (19)

1. H.W. Herr C.M. Pinsky W.F. Whitmore H.F. Oettgen M.R. Melamed Effect of intravesical bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder Cancer 51 1983 1323
2. D. Lamm D.E. Thor W.D. Winters V.D. Stogdill H.M. Radwin BCG immunotherapy of bladder cancer: inhibition of tumor recurrence and associated immune responses Cancer 48 1981 82
3. S.A. Brosman Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma J. Urol. 128 1982 27
4. E.O. Haaff S.M. Dresner T.L. Ratliff W.J. Catalona Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder J. Urol. 136 1986 820
5. D.R. Kelley E.O. Haaff M. Becich J. Lage W.C. Bauer S.M. Dresner W.J. Catalona T.L. Ratliff Prognostic value of purified protein derivative skin test and granuloma formation in patients treated with intravesical bacillus Calmette-Guerin J. Urol. 135 1985 268
6. T.L. Ratliff D.P. Gillen W.J. Catalona Requirement of a thymus dependent immune response for BCG-mediated antitumor activity J. Urol. 137 1987 155
7. J.C. Nickel A. Morales J.P.W. Heaton J.W. Costerton Ultra-structured study of the interaction of BCG with bladder mucosa after intravesical treatment of bladder cancer J. Urol. 133 1985 268-A
8. 32P Into phospholipids of Mycobacterium leprae Ann. Inst. Pasteur/Microbiol. 136A 1985 303
9. C.G. Pommier S. Inada L.F. Fries T. Takahashi M.M. Frank E.J. Brown Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes J. Exp. Med. 157 1983 1844
10. C.G. Pommier J. O’Shea T. Chused K. Yancey M. Frank T. Takahashi E.J. Brown Studies on the fibronectin receptors of human peripheral blood leukocytes J. Exp. Med. 159 1984 137
11. H.K. Kleinman M.L. McGarvey L.A. Liotta P.G. Robey E. Tryggavson G.R. Martin Isolation and characterization of type IV procollagen, laminin and heparan sulfate proteoglycan from the EHS sarcoma Biochemistry 24 1982 6188
12. M.R.G. Robinson C.C. Rigby Intravesical BCG therapy for Ta and T1 bladder tumors R.T.D. Oliver W.F. Hendry H.J. Bloom Bladder Cancer 1981 Butterworths London 287 295
13. D.L. Lamm E.E. Reichert S.C. Harris R.M. Lucio Immunotherapy of murine transitional cell carcinoma J. Urol. 128 1982 1104
14. D.F. Mosher Fibronectin Prog. Hemat. Thromb. 5 1980 111
15. F. Grinnel R.E. Billingham L. Burgess Distribution of fibronectin during wound healing in vivo J. Invest. Derm. 76 1981 181
16. D. Pode Y. Alon A.T. Horowitz I. Vlodavsky S. Biran The mechanisms of bladder tumor implantation in an in vitro model J. Urol. 136 1986 482
17. E.H. Beachey Bacterial adherence: adhesion-receptor interactions mediating the attachment of bacteria to mucosal surfaces J. Infect. Dis. 143 1981 325
18. Ratledge, C.: In: The Biology of the Mycobacteria. Edited by Rutledge, C. and Stanford, J. Academic Press, volume I, pp. 53-93, 1983.
19. Ratliff, T. L., McGarr, J. A., Abou-Zeid, C., Rook, G. A. W., Stanford, J. L., Aslanzadeh, J. and Brown, E. J.: Attachment of mycobacteria to fibronectin coated surfaces. J. Gen. Microbiol., In Press.